Ciprofibrate

HCID 2763CAS 52214-84-3

기본 정보

표준 SMILES
CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O
InChIKey
KPSRODZRAIWAKH-UHFFFAOYSA-N
분자식
C13H14Cl2O3
평균 분자량
289.15 g/mol
단동위원소 질량
288.03199967

개요

Ciprofibrate is a monocarboxylic acid, an organochlorine compound and a member of cyclopropanes. It has a role as an antilipemic drug.

이름 및 식별자

우선 이름
Ciprofibrate
IUPAC
2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid
영어명
Ciprofibrate
분자식
C13H14Cl2O3
분자량
289.15

이름 및 동의어

Ciprofibrate52214-84-32-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methylpropanoic acid2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acidCiprofibratumCiprofibratoModalimWin-35833WIN 35833DTXSID8020331Propanoic acid, 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methyl-NSC-759617
이름 더 보기
CiprobrateCiprofibric acidCipmlCiprolLipanorCiprofibrate >Ciprofibrate CRS
F8252JGO9S2-(p-(2,2-Dichlorocyclopropyl)phenoxy)-2-methylpropionic acidPropanoic acid, 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methyl-DTXCID20331CHEBI:50867Hyperlipen2-[p-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropionic acidRefChem:577246

데이터베이스 식별자

CAS
52214-84-3
PubChem CID
2763
DTXSID
DTXSID8020331
ChEMBL
CHEMBL557555
ChEBI
CHEBI:50867
UNII
F8252JGO9S
EC Number
257-744-6
Nikkaji
J10.383G

물성

구조 계산 물성

XLogP
3.4
극성 표면적
46.5 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
3
회전 가능 결합 수
4
무거운 원자 수
18

실험 및 물리화학적 성질

Endocrine DisruptorsPotential endocrine disrupting compound
Collision Cross Section171.9 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Dataset: TOXCAST; Source Identifier: DTXSID8020331]

물리화학적 성질

녹는점
114 · 114-116°
끓는 점
401.74 °C · 401.74°C (rough estimate)
밀도
1.2576 · 1.2576 (rough estimate)
굴절률
1.5209 · 1.5209 (estimate)
저장 조건
2 · 2-8°C
용해도
물에 거의 녹지 않으며, 무수 에탄올에 잘 녹고, 톨루엔에 녹습니다.

화학적 성질

Off-White to Pale Beige Solid

안전 및 규제

GHS 분류

GHS Classification · 4건

Danger

H350 (95%): May cause cancer [Danger Carcinogenicity]

P203, P280, P318, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory.

유해성 정보

Hazard Classes and CategoriesCarc. 1B (95%)

독성 정보

Drug Induced Liver Injury · 4건

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

ciprofibrate

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

안전 데이터

wgk
3
rtecs
UF0880000
HS 번호
29189900
risk_code
45
hazard_code
T
safety_code
53-22-36/37/39-45

화학 및 산업

약리 정보

ATC Code · 3건

C10AB08

C - Cardiovascular system

QC - Cardiovascular system

MeSH Pharmacological Classification · 2건

Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS.

A class of nongenotoxic CARCINOGENS that induce the production of hepatic PEROXISOMES and induce hepatic neoplasms after long-term administration.

응용 분야 · 2건

개요Ciprofibrate is a potent, long-acting hypolipidemic agent related to clofibrate, bezafibrate and fenofibrate. It is effective in types IIa, IIb, IIX and IV hyperlipoproteinemias, and produces a beneficial elevation of the anti-atherogenic HDL.

용도Ciprofibrate is a hypolipemic agent, related structurally to Clofibrate (C586910). Ciprofibrate is used as an antilipemic.

공급사50 곳

梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
衢州润东化工有限公司0570-8789886 18892685668 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
广州隽沐生物科技股份有限公司020-36607679; 13502246435 · [email protected]
T&W GROUP021-61551611 13296011611 · [email protected]

관련 반응

1건

연결된 노트

불러오는 중…